Multisensory Intervention for Premature Birth
(SOOTHE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new program called SENSE, a multisensory intervention designed to improve the health and well-being of premature babies and their parents in the NICU (Neonatal Intensive Care Unit). The program includes activities such as massage, listening to sounds, rocking, and skin-to-skin contact, all tailored to the baby's development and health. The researchers aim to determine if these activities can boost brain activity, improve parent-child interactions, and support better development up to age 2, particularly in language skills. Babies born at or before 32 weeks and enrolled in the first week of life may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative care strategies that could enhance early development in premature infants.
Do I need to stop my current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the SENSE multisensory program is safe for preterm infants?
Research has shown that the SENSE multisensory program is generally safe for premature babies. In a study with 70 preterm infants, participants in sensory activities like the SENSE program experienced no major negative effects. The program includes gentle activities such as massage, listening to calming sounds, and skin-to-skin contact, all aimed at safely supporting a baby's development.
The SENSE program provides babies with positive sensory experiences daily, and its safety is supported by research. Parents learn to perform these activities safely and effectively for their babies. The program is tailored to each baby's needs and health condition, which helps reduce any possible risks.12345Why are researchers excited about this trial?
Researchers are excited about the SENSE multisensory program because it offers a structured and evidence-based approach to enhancing sensory exposure for preterm infants, unlike the typical standard of care that varies widely and lacks set guidelines. This program provides specific tactile, auditory, visual, vestibular, and olfactory interventions tailored to each infant's needs, ensuring a consistent and comprehensive sensory experience throughout their NICU stay. By involving parents actively and offering a sensory support team when needed, the SENSE program aims to improve developmental outcomes by systematically incorporating essential sensory inputs during a critical period of infant growth.
What evidence suggests that the SENSE multisensory program is effective for preterm infants?
This trial compares the SENSE multisensory program with monitored standard care for preterm infants. Research has shown that multiple types of sensory activities can benefit preterm infants. The SENSE program, one of the treatments in this trial, includes gentle massage, listening to sounds, and skin-to-skin contact. Studies have found that these positive sensory experiences aid in the development of babies, especially those in the NICU. Early results suggest that structured sensory activities can improve brain function, parent-child bonding, and even language skills later on. By involving parents, the SENSE program aims to create a stable and caring environment for premature babies.12346
Who Is on the Research Team?
Roberta Pineda, PhD OTR/L
Principal Investigator
University of Southern California
Amit Mathur, MD
Principal Investigator
St. Louis University
Are You a Good Fit for This Trial?
This trial is for infants born prematurely (≤32 weeks gestational age) and within their first week of life. It's not suitable for those older than 7 days, with a high risk of immediate death, wards of the state, or suspected congenital anomalies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
NICU Stay
Infants receive either the SENSE multisensory program or standard care during their NICU hospitalization
Follow-up
Participants are monitored for developmental outcomes and parent-child interactions at various intervals
What Are the Treatments Tested in This Trial?
Interventions
- Monitored standard of care
- SENSE multisensory program
SENSE multisensory program is already approved in United States for the following indications:
- Improvement of neurodevelopmental outcomes in preterm infants
- Enhancement of parent-child interaction
- Support for parent mental health
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
St. Louis University
Collaborator
Washington University School of Medicine
Collaborator
University of North Carolina
Collaborator
Harvard University
Collaborator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborator
St. Louis Children's Hospital
Collaborator